chr1-205061394-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_005076.5(CNTN2):c.947C>T(p.Thr316Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00586 in 1,612,648 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T316T) has been classified as Likely benign.
Frequency
Consequence
NM_005076.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00449 AC: 684AN: 152186Hom.: 6 Cov.: 33
GnomAD3 exomes AF: 0.00497 AC: 1221AN: 245696Hom.: 6 AF XY: 0.00461 AC XY: 613AN XY: 133074
GnomAD4 exome AF: 0.00601 AC: 8773AN: 1460344Hom.: 39 Cov.: 31 AF XY: 0.00586 AC XY: 4256AN XY: 726338
GnomAD4 genome AF: 0.00449 AC: 684AN: 152304Hom.: 6 Cov.: 33 AF XY: 0.00439 AC XY: 327AN XY: 74462
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2017 | - - |
Epilepsy, familial adult myoclonic, 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2025 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at